Doctor Aflah Roohullah
Senior Lecturer in Medical Oncology,
School of Medicine
Senior Lecturer in Medical Oncology,
School of Medicine
Biography
Qualifications
- MBBS University of Otago
Organisational Unit (School / Division)
- School of Medicine
- School of Medicine
Contact
| Email: | Aflah.Roohullah@westernsydney.edu.au |
|---|---|
| Phone: | |
| Mobile: | |
| Location: | Campbelltown |
PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.
Publications
Journal Articles
- Nindra, U., Childs, S., Yoon, R., Haider, S., Hong, M., Roohullah, A., Cooper, A., Wilkinson, K., Pal, A. and Chua, W. (2024), '[In Press] Survival outcomes in older adults undergoing early phase clinical trials', Journal of Geriatric Oncology, .
- Hecht, J., Raman, S., Chan, A., Kalinsky, K., Baurain, J., Jimenez, M., Garcia, M., Berger, M., Lauer, U., Khattak, A., Carrato, A., Zhang, Y., Liu, K., Cha, E., Keegan, A., Bhatta, S., Strassburg, C. and Roohullah, A. (2023), 'Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases', ESMO Open, vol 8, no 2 .
- Kelley, R., Ueno, M., Yoo, C., Finn, R., Furuse, J., Ren, Z., Yau, T., Klumpen, H., Chan, S., Ozaka, M., Verslype, C., Bouattour, M., Park, J., Barajas, O., Pelzer, U., Valle, J., Yu, L., Malhotra, U., Siegel, A., Edeline, J., Vogel, A., Akce, M., Ales Diaz, I., Alves, G., Anand, S., Arslan, C., Asselah, J., Assenat, E., Aubin, F., Bai, L., Bai, Y., Bates, S., Begbie, S., Ben-Aharon, I., Beri, N., Berres, M., Blanc, J., Borbath, I., Bordonaro, R., Brandi, G., Burgoyne, A., Butthongkomvong, K., Cao, K., Carballido, M., Camandaroba, M., Chang, S., Chen, J., Chen, M., Chen, X., Roohullah, A. and et al, .. (2023), 'Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966) : a randomised, double-blind, placebo-controlled, phase 3 trial', The Lancet, vol 401, no 10391 , pp 1853 - 1865.
- Nindra, U., Shivasabesan, G., Childs, S., Yoon, R., Haider, S., Hong, M., Cooper, A., Roohullah, A., Wilkinson, K., Pal, A. and Chua, W. (2023), 'Time toxicity associated with early phase clinical trial participation', ESMO Open, vol 8, no 6 .
- Min, S., Roohullah, A., Tognela, A., Jalali, A., Lee, M., Wong, R., Shapiro, J., Burge, M., Yip, D., Nott, L., Zimet, A., Lee, B., Dean, A., Steel, S., Wong, H., Gibbs, P. and Lim, S. (2022), 'Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting : real-world data in an Australian population', Asia-Pacific Journal of Clinical Oncology, vol 18, no 2 , pp 56 - 63.
- Scott, K., Mann, T., Fatima, S., Sajinovic, M., Razdan, A., Kim, R., Cooper, A., Roohullah, A., Bryant, K., Kanapaddala Gamage, K., Harman, D., Vafaee, F., Graham, G., Church, W., Russell, P., Dong, Q. and Souza, P. (2021), 'Human Group IIA Phospholipase A2 : three decades on from its discovery', Molecules, vol 26, no 23 .
- Lim, S., Ip, E., Ng, W., Chua, W., Asghari, R., Roohullah, A., Descallar, J., Henderson, C., Spring, K., Souza, P. and King, M. (2019), 'Health-related quality of life during chemoradiation in locally advanced rectal cancer : impacts and ethnic disparities', Cancers, vol 11, no 9 .
- Panizza, B., Souza, P., Cooper, A., Roohullah, A., Karapetis, C. and Lickliter, J. (2019), 'Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)', EBioMedicine, vol 50 , pp 433 - 441.